ViroCyt Acquired by Sartorius

News   Jul 18, 2016

 
ViroCyt Acquired by Sartorius
 
 
 

RELATED ARTICLES

Chemical Compound Class Possesses Potential for Treating Zika Virus

News

A new and promising class of chemical compounds has major potential for treating Zika virus and respiratory syncytial virus, or RSV, according to a new study.

READ MORE

Lab Innovations 2018 – Registration Opens and Keynotes Announced

News

Learn and earn CPD points at the UK’s only lab-dedicated showcase and scientific seminar series.

READ MORE

BioAscent Secures Investment to Expand its Integrated Drug Discovery Services

News

£1.6m investment recognises BioAscent’s unique capabilities.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy